Marcin Drop
Krakow, MA, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
5-HT6 Receptor Inverse Agonists Modulate Diabetic Neuropathic Pain in Female Rats: Evidence for 5-HT6 Receptor Constitutive Activity.
Journal: Journal of neurochemistry
Published: March 04, 2025
5-HT6 receptor neutral antagonists protect astrocytes: A lesson from 2-phenylpyrrole derivatives.
Journal: European journal of medicinal chemistry
Published: April 26, 2024
Neuropathic pain-alleviating activity of novel 5-HT6 receptor inverse agonists derived from 2-aryl-1H-pyrrole-3-carboxamide.
Journal: Bioorganic chemistry
Published: May 31, 2021
2-Phenyl-1H-pyrrole-3-carboxamide as a New Scaffold for Developing 5-HT6 Receptor Inverse Agonists with Cognition-Enhancing Activity.
Journal: ACS chemical neuroscience
Published: March 11, 2021
A dual-acting 5-HT6 receptor inverse agonist/MAO-B inhibitor displays glioprotective and pro-cognitive properties.
Journal: European journal of medicinal chemistry
Published: July 08, 2020
mTOR activation by constitutively active serotonin6 receptors as new paradigm in neuropathic pain and its treatment.
Journal: Progress in neurobiology
Published: December 17, 2019
Novel multitarget 5-arylidenehydantoins with arylpiperazinealkyl fragment: Pharmacological evaluation and investigation of cytotoxicity and metabolic stability.
Journal: Bioorganic & medicinal chemistry
Published: April 16, 2019
Dual 5-HT6 and D3 Receptor Antagonists in a Group of 1H-Pyrrolo[3,2-c]quinolines with Neuroprotective and Procognitive Activity.
Journal: ACS chemical neuroscience
Published: March 22, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026